Home therapy with LMWH in deep vein thrombosis: Randomized study comparing single and double daily administrations

Angiology

Volumn 58, Issue 3, 2007, Pages 316-322

  Bellosta, Raffaello ^a,c   Ferrari, Patrizio ^b   Luzzani, Luca ^a   Carugati, Claudio ^a   Cossu, Luisa ^a   Talarico, Matteo ^a   Sarcina, Antonio ^a  

^a Vascular Surgery Unit Poliambulanza Foundation Hospital   (Italy)

^b Alfa Wassermann SpA   (Italy)

^c NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTICOAGULANT AGENT; NADROPARIN; PARNAPARIN;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE COURSE; DOPPLER FLOWMETRY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FEMORAL VEIN; FOLLOW UP; HEMATOMA; HEPARINIZATION; HOME CARE; HUMAN; INJECTION SITE BLEEDING; INJECTION SITE BURNING; LEG THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POPLITEAL VEIN; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RECANALIZATION; RELAPSE; RISK MANAGEMENT; SIDE EFFECT; SURAL VEIN; THROMBOSIS PREVENTION; TREATMENT OUTCOME; VEIN; VEIN INSUFFICIENCY; VEIN SURGERY; VEIN VALVE; VENOUS THROMBOEMBOLISM;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; FEMORAL VEIN; HEMORRHAGE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; NADROPARIN; PATIENT COMPLIANCE; PILOT PROJECTS; POPLITEAL VEIN; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RECURRENCE; SELF ADMINISTRATION; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, COLOR; VENOUS THROMBOSIS;

EID: 34250712893     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319707301757     Document Type: Article

References (17)

1. Leizorovicz A.: Comparison of the efficacy and safety of low molecular weight heparins and unfractionated heparin in the treatment of deep venous thrombosis: An updated meta-analysis. Drugs 52 (suppl 7). 30-37, 1996.
2. Meissner MH, Manzo RA, Bergelin RO, Strandness DE Jr: Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 18: 596-605, 1993.
3. Fihn S., McDonnel M., Martin D.,, et al. Risk factors for complications of chronic anticoagulation. Ann Intern Med 118: 511-520, 1993.
4. Turkstra F., Koopman MM, Buller HR: The treatment of deep vein thrombosis and pulmonary embolism. Thromb Haemost 78: 489-496, 1997.
5. Gould MK, Dembitzer AD, Doyle RL: Low molecular-weight heparins and unfactionated heparin for treatment of acute deep venous thrombosis: A meta-analysis of randomized controlled trials. Ann Intern Med 130: 800-809, 1999.
6. Lopez-Beret P., Orgaz A., Fontcuberta J., Doblas M.: Low molecular weight heparin versus oral anticoagulants in the long-term treatment of deep venous thrombosis. J Vasc Surg 33: 77-90, 2001.
7. Prandoni P., Lensing Awa, Büller HR,, et al. Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis. Lancet 339: 441-445, 1992
8. Kirchmaier CM, Lindhoff-Last E., Rübesam D.,, et al. Regression of deep vein thrombosis by i.v.: Administration of a low molecular weight heparin: Results of a pilot study. Thromb Res 73: 337-348, 1994.
9. Killewich LA, Bedford GR, Beach KW, Stradness DE Jr: Spontaneous lysis of deep venous thrombi: Rate and outcome. J Vasc Surg 9: 89-97, 1989.
10. Hull RD, Raskob GE, Pineo GF,, et al. Subcutaneous low molecular weight heparin compared with continuous intravenous heparin in the treatment of proximal vein thrombosis. N Engl J Med 326: 975-982, 1992.
11. Koopman Mmw, Prandoni P., Piovella F.,, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 334: 682-687, 1996.
12. Schulman S., Rhedin AS, Lindmarker P.,, et al. Duration of anticoagulation trial study group: A comparison of six weeks with six month of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 332: 1661-1665, 1995.
13. Van Bemmelen PS, Bedford G., Beach K., Stradness DE Jr: Quantitative segmental evaluation of venous valvular reflux with duplex ultrasound scanning. J Vasc Surg 10: 425-443, 1989.
14. Vasdekis SN, Clarke GH, Nicolaides AN: Quantification of venous reflux by means of duplex scanning. J Vasc Surg 10: 670-677, 1989.
15. Haenen JH, Janssen MC, van Langen H.,, et al. Duplex ultrasound in the hemodynamic evaluation of the late sequelae of deep vein thrombosis. J Vasc Surg 27: 472-478, 1998.
16. Van Ramshorst B., van Bemmelen P., Hoeneveld H.,, et al. Thrombus regression in deep venous thrombosis: Quantification of spontaneous thrombolysis with duplex scanning. Circulation 86: 414-419, 1992.
17. Buller HR, Agnelli G., Hull RD, Hyers TM, Prins MH, Raskob GE: Antithrombotic therapy for venous thromboembolic disease. Chest 126: 401S - 428S, 2004.